Detalhes bibliográficos
Ano de defesa: |
2008 |
Autor(a) principal: |
Campos, Afonso Celso Soares |
Orientador(a): |
Não Informado pela instituição |
Banca de defesa: |
Não Informado pela instituição |
Tipo de documento: |
Dissertação
|
Tipo de acesso: |
Acesso aberto |
Idioma: |
por |
Instituição de defesa: |
Não Informado pela instituição
|
Programa de Pós-Graduação: |
Não Informado pela instituição
|
Departamento: |
Não Informado pela instituição
|
País: |
Não Informado pela instituição
|
Palavras-chave em Português: |
|
Link de acesso: |
http://www.repositorio.ufc.br/handle/riufc/4185
|
Resumo: |
The Brazilian Peppertree (Myracrodruon urundeuva Allemão) is a medicinal plant popularly known in the treatment of gynecological problems, such as cervicitis, vaginitis and ectopies, which pharmaceutical form in cream is 15%, used for more than ten years by the Live Pharmacy Program. One aimed to study the use and efficiency of Brazilian Peppertree in gynecology; record and quantify possible adverse and phytotherapic reactions. It is an observatory, prospective study, of the open type and non comparative of medicine use. Developed in a Health Unit, from regional IV in Fortaleza-CE. The study was composed by 33 women that received indication and prescription of Brazilian Peppertree’s vaginal cream, but only 18 completed all the phases of the study. The data were collected between January and June 2008, by accompaniment of women who concluded the study. One used as technique the individual interview pre and post treatment; the use of clinical information given by the responsible gynecologist, besides a form to record the clinical data. The results demonstrated that no adverse reaction was reported and that the cream was effective in the treatment of the diseases (Cervicitis and Ectopies). One concludes, thus, that the findings confirm all the pharmacological effects already detected concerning the Brazilian Peppertree and that it does not cause any adverse reaction, confirming, this way, what preaches the new National Policy of Medicinal Plants, regarding women’s health. |